Elevation Oncology rises on CEO, CFO appointments

Elevation Oncology

13/07/2023 14:12

** Shares of drug developer Elevation Oncology Inc  ELEV.O 
up 1.3% at $1.53 before the bell
    ** Co appoints Joseph Ferra as CEO; Ferra was previously
Interim CEO and CFO
    ** Co also appoints Tammy Furlong as CFO; promoted from her
previous role as vice president of Finance and Accounting
    ** ELEV shares up about ~60% YTD
    

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))